Gastric CSCs were first reported by Takaishi et al. in experiments showing that CD44-positive gastric cancer cells have stem cell-like properties and showed an increased resistance to traditional chemotherapies and radiotherapies [15]. This evidence concerns the gene CD44 and gastric cancer.